M. Griffith Investment Services
August 24, 2018

Michael Cohen could be key witness in state investigation of Trump charity

Yana Paskova/Getty Images(NEW YORK) -- Michael Cohen’s striking accusation on Tuesday that then-candidate Donald Trump directed him to negotiate hush agreements to help the campaign, which violated campaign finance laws, sharpened interest in a separate legal probe connected to the president -- the ongoing investigation of his family charity. Cohen, Trump’s former fixer and personal attorney, could become a key witness in that probe. Less than 24 hours after Cohen pleaded guilty to eight felonie..
August 23, 2018

With new special envoy, Pompeo heading to N Korea amid ‘deadlock’ over denuclearization

iStock/Thinkstock(WASHINGTON) -- Amid what North Korea calls a "deadlock" in denuclearization talks, Secretary of State Mike Pompeo will travel to Pyongyang next week, with the new Special Representative for North Korea, Steve Biegun, in tow. This will be Pompeo's fourth trip to Pyongyang, his third as the top U.S. diplomat. But it comes after North Korea said talks have been 'derailed' after the U.S. demanded the country reveal its secret nuclear facilities -- which North Korea c..
August 23, 2018

Suspected Nazi labor camp guard unlikely to be prosecuted in Germany: Authorities

U.S. Department of Justice(NEW YORK) -- Jakiw Palij, a man authorities say is a former Nazi concentration camp guard who was deported to Germany this week, is unlikely to be prosecuted for war crimes there due to insufficient evidence. Justice Department officials say Palij served as an armed guard at a death camp in Nazi-occupied Poland. His deportation came 25 years after Palij, who had been living in Queens, New York, was first accused of lying about his Nazi past to obtain a U.S. visa. In 20..
August 23, 2018

Congo approves more experimental Ebola treatments in race to contain growing outbreak

iStock/Thinkstock(NEW YORK) -- The Democratic Republic of the Congo has approved four more experimental treatments for the deadly Ebola virus, in an effort to contain a growing outbreak in its restive eastern region that has already killed dozens. The country's health ministry announced late Tuesday that the ethics committee had authorized the use of Remdesivir, an antiviral drug made by Gilead Sciences in Israel; ZMapp, a monoclonal antibody treatment developed by San Diego-based Mapp Biop..